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ABSTRACT
Objective: Multidrug-resistance (MDR) is defined as an acquired non-susceptibility to at least one agent in three or more antimicrobial categories. 
MDR can be caused by several factors, including the misuse of antibiotics. Resistance to antibiotics still poses a global challenge, especially in Indonesia. 
This study aimed to identify patterns of MDR in neonatal intensive care unit (NICU) at the Central Java Hospital, during the period of January 2014 to 
December 2015.
Methods: The study was conducted using a descriptive retrospective design. The research population comprised 225 patients. The patient inclusion 
criteria were neonatal patients treated in NICU ward with infection diagnosis. All patients had culture and sensitivity examinations on their bloods. 
The culture and sensitivity examinations were performed by microbiology clinicians.
Results: The most common infection type was sepsis (60%). The most common bacteria found in the blood specimen of patients in the NICU ward 
was Gram-negative bacteria with a 72% rate; the other was Gram-positive bacteria. Bacteria which infected patients include Klebsiella pneumoniae 
ssp. pneumoniae, Pseudomonas aeruginosa, Burkholderia cepacia, Acinetobacter baumannii, Enterobacter cloacae ssp. cloacae, Serratia marcescens, 
Staphylococcus haemolyticus, and Staphylococcus epidermidis. The research result showed that 97.8% MDR cases were reported in the NICU ward. 
Antibiotics which were still potent for all bacteria found in NICU patients were tigecycline, meropenem and ciprofloxacin (for Gram-negative bacteria) 
and tigecycline, linezolid, nitrofurantoin, moxifloksacin, and vancomycin (for Gram-positive bacteria).
Conclusion: A high percentage of MDR occurred in NICU patients. Sepsis is the most common diagnosis in NICU patients. The usage of third generation 
antibiotics should be limited and regulated systematically.
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INTRODUCTION
Antibiotic resistance is a global issue today, which results in prolonged 
illness, disability and death. The World Health Organization (WHO) 
reported that antibiotic resistance has hit the world due to genetic 
change of bacteria, misuse of antibiotics for livestock and fishery 
products, and usage of antibiotics in non-infection diseases. Resistance 
of Klebsiella pneumoniae to carbapenem antibiotic has spread globally. 
K. pneumoniae bring about nosocomial infection in pneumonia, 
bloodstream infection (BSI), and infections in newborn babies treated 
in neonatal intensive care unit (NICU).
Methicillin-resistant Staphylococcus aureus (MRSA) has been found in 
communities and hospitals. WHO encourages coordinated efforts from 
all stakeholders to minimize the spread of antibiotic resistance [1]. 
Antibiotic resistance has also spread to Asian countries. In Nepal 
hospitals, antibiotic resistance is dominated by Gram-negative bacteria. 
These bacteria are resistant to quinolone and sulfonamide [2]. In 
Southern India, multidrug-resistance (MDR) incidences increase 
by 20%, particularly Gram-negative bacteria, which are resistant to 
carbapenem [3]. In Indonesia, antibiotic resistance is not different from 
that of other Asian countries. Resistance due to Gram-negative bacteria 
has been reported by 10 teaching hospitals in Indonesia. One of them is 
perinatology, which occurred in a patient’s ward in RSUP, Sanglah Bali.
Antibiotic resistance in patients of sepsis neonates is caused by Serratia 
marcescens [4]. Intensive care units, including NICU, are the most 
sensitive sections in a hospital because that is where patients with 
complication or the equipment used to treat life-threatening injuries are 
kept. Infections in NICU are generally caused by healthcare-associated 
infections (HAIs). HAIs are believed to be the direct and indirect cause of 
increases in morbidity, mortality and economic burden [5]. Bloodstream 
infections (BSIs) caused by commensal species are one of the infection 
types most commonly found in NICU (59%) and it is life threatening [6].
Bacteria pattern and antibiotic sensitivity vary among countries and 
hospitals. Even in a single hospital, bacteria pattern vary among wards. 
Bacteria pattern variation also occurs across time. Since the 1950s, 
Staphylococcus aureus, Gram-negative bacteria and coagulase-negative 
staphylococci (CoNS) are the predominant causes of nosocomial 
infections in NICU in American hospitals. Today, Gram-positives, including 
MRSA, CoNS and vancomycin-resistant enterococci are MDR bacteria [7]. 
The same MDR was also reported to occur in NICUs in Australian, North 
American, European, and even Brazilian hospitals in the 2000s [8-10]. 
Therefore, the study’s aims are to identify patterns of MDR in NICU in 




All neonatal patients in the NICU ward who had infections due to bacteria 
and on whom antibiotic sensitivity culture examination was performed.
Sample exclusion criteria
Neonatal patients in the NICU ward who had infections and have 
incomplete medical records. The protocol was approved by Medical and 
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Health Research Ethics Committee, Faculty of Medicine, Gadjah Mada 
University (KE/FK/253/EC/2016).
Patient evaluation
The collected data of patients included characteristics of research 
subjects, that is, age, gender, birth history, diagnosis, length of stay 
(LoS), clinical outcome, and type of bacteria found.
Antimicrobial susceptibility test
This study was a descriptive study of data collected from a laboratory 
record of NICU in a hospital in Central Java. The collected data were all 
culture and sensitivity results using blood specimen. It was conducted 
within the period of January 2014-December 2015. Blood culture 
sensitivity examination was performed following the disc diffusion 
method as well as with agar dilution minimal inhibitory concentration 
method, using Vitek 2 (bioMérieux).
Statistical analysis
Research characteristic data, that is, gender, age, birth history, 
diagnosis, sepsis classification, LoS, clinical outcome, type of bacteria 
found, MDR, and bacterial resistance pattern against antibiotics were 
analyzed descriptively.
RESULTS
During the research period from January 2014 to December 2015, 225 
neonatal patients were treated in the NICU of Central Java hospital. 
A 135 (60%) patients died (Table 1).
The most common diagnosis of neonatal patients treated in NICU was 
sepsis infection, which was confirmed by patients’ blood cultures. The 
neonatal characteristics are shown in Table 1. In general, the reason for 
the patients being admitted was infection and having baby birth weight 
below 1500 g. 90 neonatal patients (40%) had sepsis infection along 
with other infections.
Microorganisms identified in patients’ blood cultures are presented 
in Table 2. The most commonly identified microorganism was 
Gram-negative bacteria (72%) which consisted of K. pneumoniae 
ssp. pneumoniae, Pseudomonas aeruginosa, Burkholderia cepacia, 
Acinetobacter baumannii, Enterobacter cloacae ssp. cloacae, and 
S. marcescens. Identified Gram-positive bacteria were Staphylococcus 
haemolyticus and Staphylococcus epidermidis. All neonatal patients 
used peripheral line cannulation, which most likely played a role in 
patients’ LoS in NICU. Most of the neonates (85%) were treated for over 
7 days (Table 1).
Antibiotic resistance data of Gram-negative bacteria can be seen in 
Table 3. K. pneumoniae ssp. pneumoniae showed high resistance against 
penicillin and cephalosporin, aminoglycoside, as well as cotrimoxasole 
and piperacillin/tazobactam. Similar pattern was found in A. baumannii. 
P. aeruginosa showed a high resistance against all anti-pseudomonas 
antibiotics (25-100%). B. cepacia showed moderate resistance against 
ceftazidime and levofloxacin (<20%). E. cloacae ssp. cloacae showed 
resistance against penicillin and some cephalosporin. S. marcescens 
was resistant to tobramycin. Gram-positive bacteria, S. haemolyticus 
and S. epidermidis, have similar resistance pattern against penicillin, 
erythromycin, aminoglycoside, fluoroquinolone, clindamycin, 
rifampicin, and cotrimoxazole.
Antibiotic resistance data of Gram-positive bacteria can be seen in 
Table 4. Like S. epidermidis, S. haemolyticus showed high resistance 
against benzylpenicillin, erythromycin, clindamycin, ciprofloxacin, 
levofloxacin and rifampicin, gentamicin and cotrimoxazole (20-100%). 
S. haemolyticus showed moderate resistance against moxifloxacin, 
nitrofurantoin, and vancomycin (<20%). However, S. epidermidis 
showed high resistance against vancomycin (25%).
The choice of sensitive-antibiotics for Gram-negative and Gram-positive 
microorganisms was presented in Table 5.
DISCUSSION
MDR caused by nosocomial infection has drawn a lot of interest 
from people across the globe, especially since the neonatal patients 
are highly vulnerable to infections during their stay in the hospital. 
Neonatal infections are believed to be the biggest contributor to 
mortality and morbidity worldwide. In the WHO report, it was 
observed that about 4 million neonatal mortalities across the 
world occur due to infections, and about 1 million of them occur 
due to sepsis or pneumonia [11]. In this study, 225 neonatal 
patients admitted in NICU had BSIs. In developed countries, most 
nosocomial infections in neonatal patients are caused by BSIs and 
pneumonia [12], while in developing countries, most of the baby 
deliveries are performed at home, so various infections might occur, 
such as septicaemia, meningitis, respiratory infections, diarrhea and 
neonatal tetanus, although, BSIs poses a greater threat [13]. Neonatal 
sepsis incidents in Asia occur within the rate of 7.1-38/1000 live 
births. The most common bacteria causing neonatal sepsis in Asian 
and African countries are Gram-negative bacteria [2-4,13]. The result 
of this study also revealed that BSIs in NICU was dominated by Gram-
negative bacteria (72% or 162 isolates out of 225 isolates). Around 
Table 1: General characteristics of the admitted 
























EONS: Early onset neonatal sepsis, LONS: Late onset neonatal sepsis
Table 2: The identified microorganisms in blood culture
Microorganism n=225 (%)
Gram-negative organisms
K. pneumoniae ssp. pneumoniae 49 (21.8)
P. aeruginosa 31 (13.8)
B. cepacia 21 (9.3)
A. baumannii 21 (9.3)
E. cloacae ssp. cloacae 20 (8.9)
S. marcescens 20 (8.9)
Gram-positive organisms
S. haemolyticus 32 (14.2)
S. epidermidis 31 (13.8)
MDR 220 (97.8)
Non-MDR 5 (2.2)
K. pneumoniae ssp. pneumoniae: Klebsiella pneumoniae ssp. pneumoniae, 
P. aeruginosa: Pseudomonas aeruginosa, B. cepacia: Burkholderia cepacia, 
A. baumannii: Acinetobacter baumannii, E. cloacae ssp. Cloacae: Enterobacter 
cloacae ssp. cloacae, S. marcescens: Serratia marcescens, S. haemolyticus: 
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35% dominant bacteria were K. pneumoniae ssp. pneumoniae and 
P. aeruginosa. The research result was in line with the bacteria patterns 
found to be sources of infections in patients treated in NICU in Suez 
Canal University Hospital, Ismalia, Egypt, and other surveillances in 
Egypt [14,15]. Klebsiella sp. has for long been known as the cause 
of sepsis, urinary tract infection and pneumonia in NICU. In the 
1970s, there was an outbreak in NICU due to kanamycin-resistant 
Klebsiella sp. Furthermore, extended-spectrum beta-lactamase-
producing (ESBL) Klebsiella sp. is now found to be resistant to third-
generation cephalosporins [6]. The study performed in several clinics 
in Nepal also found the ESBL Klebsiella sp. to be resistant to third 
generation cephalosporin. Incidences of ESBL Klebsiella sp. which 
Table 5: Sensitive‑antibiotic choice for the microorganisms
Organism Sensitive‑antibiotic
Gram-negative
K. pneumoniae ssp. 
pneumoniae
Cefotaxime, ertapenem, imipenem, 
ciprofloxacin, levofloxacin, tigecycline, 
fosfomycin
P. aeruginosa None
B. cepacia Cotrimoxazole, levofloxacin, ceftazidime
A. baumannii Imipenem, meropenem, tigecycline, 
ceftriaxone, ciprofloxacin, cotrimoxazole
E. cloacae ssp. cloacae Cefotaxime, ceftriaxone, cefuroxime, 
cefepime, imipenem, meropenem, 
ciprofloxacin, gentamicin, amikacin, 
tobramycin
S. marcescens Ertapenem, imipenem, levofloxacin, 
piperacillin/tazobactam
Gram-positive
S. haemolyticus Moxifloxacin, tigecycline, linezolid, 
nitrofurantoin, vancomycin
S. epidermidis Moxifloxacin, tigecycline, amikacin, 
linezolid, nitrofurantoin
K. pneumoniae ssp. pneumoniae: Klebsiella pneumoniae ssp. pneumoniae, 
P. aeruginosa: Pseudomonas aeruginosa, B. cepacia: Burkholderia 
cepacia, A. baumannii: Acinetobacter baumannii, E. cloacae ssp. cloacae: 
Enterobacter cloacae ssp. cloacae, S. marcescens: Serratia marcescens, 
S. haemolyticus: Staphylococcus haemolyticus, S. epidermidis: Staphylococcus 
epidermidis
Table 3: Antibiotic resistance of Gram‑negative organisms
Antibiotics K. pneumonia ssp. 
pneumoniae (%)
P. aeruginosa (%) A. baumannii (%) E. cloacae ssp. cloacae (%) S. marcescens (%)
Penicillin






Cefotaxime 0 100 0
Ceftazidime 93.3 50 80 12.5
Ceftriaxone 100 20 12.5
Cefepime 93.3 57.2 50 7.1
Carbapenem
Ertapenem 0 0
Imipenem 0 50 0 0 0
Meropenem 25 0 6.2
Quinolone
Ciprofloxacin 0 33.3 20 14.3
Levofloxacin 0 50 50 25 0
Aminoglycoside
Amikacin 23.3 75 66.7 5.9 5.3
Gentamicin 93.1 71.4 50 11.8 10.5










K. pneumoniae ssp. pneumoniae: Klebsiella pneumoniae ssp. pneumoniae, P. aeruginosa: Pseudomonas aeruginosa, A. baumannii: Acinetobacter baumannii, E. cloacae ssp. 
Cloacae: Enterobacter cloacae ssp. cloacae, S. marcescens: Serratia marcescens
Table 4: Antibiotic resistance of Gram‑positive organisms
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was found to be resistant to cephalexin and ceftriaxone are 14.29 and 
3.5%, respectively [16,17].
The study by Lamichhane et al. (2014) revealed that MDR incidences 
in non ESBL Klebsiella sp. is also very high, being around 50%. The 
bacteria show resistance to cephalexin and ceftriaxone [3]. Incidences 
of Klebsiella sp. resistance to ceftriaxone in the US is around 6.6% and in 
Latin America, it is much higher (around 30-50%) [18]. This study also 
found Klebsiella sp. being resistant to third-generation cephalosporin 
(ceftriaxone and ceftazidime) with 100 and 93.3% rates (respectively). 
In addition, the Klebsiella sp. identified in this study also showed 
resistance against aminoglycoside, cotrimoxazole and piperacillin/
tazobactam. It showed that the MDR in NICU at the Central Java hospital 
was alarming. Lack of study in Indonesia leads to a lack of national 
awareness of antibiotic resistance control, although it is very likely that 
MDR also occurs in various regions in Indonesia. There is even MDR 
variation in different units in a single hospital. In 2016, Indonesian 
government started a national surveillance on the qualitative and 
quantitative usage of antibiotics to get a picture of rationality of 
antibiotic usage in several teaching hospitals, to create a map of the 
influence of rationality of antibiotic prescription for MDR and national 
antibiotic control strategy.
Gram-negative bacteria are potent organisms which cause BSIs. 
Gram-negative bacteria are the more rapidly acquired MDR than 
the Gram-positive bacteria. Several studies reveal major threats 
due to Gram-negative bacteria, particularly to patients admitted 
in the hospital. The increasing usage of antibiotic carbapenem 
leads to carbapenem-resistant Gram-negative incidences in several 
countries [18,19]. Carbapenem is usually used for MDR A. baumannii 
which eventually causes carbapenem-resistant A. baumannii, 
commonly found in sputum and urine specimens [3]. MDR 
A. baumannii occur in patients with immunosuppression or serious 
illness. Furthermore, a prolonged stay in the intensive care unit, 
including NICU, also makes it easier for MDR A. baumannii, which 
comes from ventilation equipment and air conditioners [20,21]. This 
study found A. baumannii to be resistant to penicillin, cephalosporin, 
fluoroquinolone, aminoglycoside, tetracycline, and cotrimoxazole but 
it is still being sensitive to carbapenem.
Another dangerous Gram-negative bacteria are P. aeruginosa. 
P. aeruginosa infection is known to be death sources in sepsis 
and pneumonia. P. aeruginosa can be as a result of transmission 
from resuscitation equipment, humidifiers, incubator, and other 
equipment in NICU. Another source of transmission of P. aeruginosa 
is the hands of health-care workers [5]. The incidence of P. aeruginosa 
resistance in one of Tamil Nadu hospitals in India is over 50% for 
all  β-lactam  antibiotics,  aminoglycoside,  and  fluoroquinolone  [22]. 
P. aeruginosa identified in NICU in the present study showed 
resistance  against  all  β-lactam  antibiotics,  aminoglycoside,  and 
fluoroquinolone, as well as carbapenem at the rate of 25-100%. 
There was practically no anti-pseudomonas antibiotic left for therapy 
in NICU.
S. epidermidis and S. hemoliticus are part of CoNS. CoNS isolate showed 
that MDR resulted from its ability to form biofilm. Resistance against 
CoNS, similar to other bacteria, can be caused by overuse of antibiotics. 
In patients admitted in NICU, CoNS can form biofilm in the form of 
colonization, worsened by the severity of the disease suffered by 
preterm neonatal patients [23]. Nosocomial infections in Australia, 
North America, and Europe are mostly caused by CoNS with 48-75% 
incidences [8-10]. Although nosocomial infection incidence by CoNS is 
high, it rarely leads to death. From the study in NICU at the central Java 
hospital, only antibiotics tigecycline and linezolid were found not to be 
resistant to CoNS bacteria.
CONCLUSION
Considering the rate of MDR in the NICU in one of the hospitals 
in central Java, there should be concerted efforts by the hospital, 
coordinated by the antibiotic resistance control team to reduce MDR 
rate, especially in NICU, and to improve patients’ therapy outcome. The 
usage of third generation antibiotics should be limited and regulated 
systematically.
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